ConductScience.org, home

Paper39796264

A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases.

Khoon L and 1 other. Int J Mol Sci, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases. Papers, record 39796264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39796264

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.29, provisional
iCite
Revised in PubMed
2025-05-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Khoon LLynnhttps://orcid.org/0009-0006-1784-5837
2Piran RRonhttps://orcid.org/0000-0001-7751-696X

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptor, PAR-2Major topic
Autoimmune DiseasesMajor topic
Humans
Animals
Signal Transduction
Inflammation
Diabetes Mellitus, Type 1
Inflammatory Bowel Diseases

Source PubMed

Download CSV of topics

References89

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133763056Proteinase-Mediated Macrophage Signaling in Psoriatic Arthritis.Front Immunol2020https://conductscience.org/library/papers/33763056PubMed
239301020Protease-Activated Receptor 2 in inflammatory skin disease: current evidence and future perspectives.Front Immunol2024https://conductscience.org/library/papers/39301020PubMed
338670065Principles and therapeutic applications of adaptive immunity.Cell2024https://conductscience.org/library/papers/38670065PubMed
427156434Rheumatoid arthritis.Lancet2016https://conductscience.org/library/papers/27156434PubMed
533823532Deficiency of protease-activated receptor (PAR) 1 and PAR2 exacerbates collagen-induced arthritis in mice via differing mechanisms.Rheumatology (Oxford)2021https://conductscience.org/library/papers/33823532PubMed
616039337Sjögren's syndrome.Lancet2005https://conductscience.org/library/papers/16039337PubMed
712795636A novel serine protease predominately expressed in macrophages.Biochem J2003https://conductscience.org/library/papers/12795636PubMed
83675011Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis.Ann Rheum Dis1987https://conductscience.org/library/papers/3675011PubMed
930448290Systemic lupus erythematosus: Diagnosis and clinical management.J Autoimmun2019https://conductscience.org/library/papers/30448290PubMed
1016847277Type 1 diabetes: pathogenesis and prevention.CMAJ2006https://conductscience.org/library/papers/16847277PubMed
1134294936Pathology of autoimmune hepatitis.Pathologica2021https://conductscience.org/library/papers/34294936PubMed
1224415853Immunopathology of inflammatory bowel disease.World J Gastroenterol2014https://conductscience.org/library/papers/24415853PubMed
1334930943The activation fragment of PAR2 is elevated in serum from patients with rheumatoid arthritis and reduced in response to anti-IL6R treatment.Sci Rep2021https://conductscience.org/library/papers/34930943PubMed
1436618407Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment.Front Immunol2022https://conductscience.org/library/papers/36618407PubMed
1523647384Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.J Neurochem2013https://conductscience.org/library/papers/23647384PubMed
16156555212-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice.Br J Pharmacol2005https://conductscience.org/library/papers/15655521PubMed
1737131291Crohn's disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice.Gut Microbes2023https://conductscience.org/library/papers/37131291PubMed
1815475570Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking.Mol Pharmacol2005https://conductscience.org/library/papers/15475570PubMed
1933120736Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy.Medicine (Baltimore)2020https://conductscience.org/library/papers/33120736PubMed
2032682869Treatment of Multiple Sclerosis: A Review.Am J Med2020https://conductscience.org/library/papers/32682869PubMed

See all 89 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42737495PhageScout: Protease Cleavage Site Prediction Using an Experimental Substrate Phage Display Motif-Based Approach.Int J Mol Sci2026https://conductscience.org/library/papers/42737495PubMed
42693238Proteomic analysis of pancreatic endocrine cells by mechanistic single-cell isolation identifies membrane pathways.Exp Mol Med2026https://conductscience.org/library/papers/42693238PubMed
41002416Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells.Cells2025https://conductscience.org/library/papers/41002416PubMed
40487592Neuroprotection induced by protease-activated receptor 2 activation is independent of Gq signalling.Brain Neurosci Adv2025https://conductscience.org/library/papers/40487592PubMed
39891111Protease-activated receptors in vascular smooth muscle cells: a bridge between thrombo-inflammation and vascular remodelling.Cell Commun Signal2025https://conductscience.org/library/papers/39891111PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F2RL12150PubTator's text mininghttps://conductscience.org/library/genes/2150

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39796264

GET https://conductscience.org/api/papers/v1/39796264/references?page=2